(Q40475723)

20 September 2017

title

A mutation in the envelope protein fusion loop attenuates mouse neuroinvasiveness of the NY99 strain of West Nile virus. (English)

1 reference

20 September 2017

0 references

6

Alan D T Barrett

1 reference

20 September 2017

7

David W C Beasley

1 reference

20 September 2017

2

Li Li

1 reference

20 September 2017

Shuliu Zhang

1

1 reference

20 September 2017

Sara E Woodson

series ordinal

3

1 reference

20 September 2017

Claire Y-H Huang

series ordinal

4

1 reference

20 September 2017

Richard M Kinney

series ordinal

5

1 reference

20 September 2017

language of work or name

English

0 references

publication date

27 June 2006

1 reference

20 September 2017

1 reference

20 September 2017

volume

353

1 reference

20 September 2017

issue

1

1 reference

20 September 2017

page(s)

35-40

1 reference

Mutational Evidence for an Internal Fusion Peptide in Flavivirus Envelope Protein E

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.025

ChimeriVax-West Nile virus live-attenuated vaccine: preclinical evaluation of safety, immunogenicity, and efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.025

Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.025

Mouse neuroinvasive phenotype of West Nile virus strains varies depending upon virus genotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.025

Limited evolution of West Nile virus has occurred during its southwesterly spread in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.025

Envelope protein glycosylation status influences mouse neuroinvasion phenotype of genetic lineage 1 West Nile virus strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.025

Recent advancement in flavivirus vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.025

Localization and Characterization of Flavivirus Envelope Glycoprotein Cross-Reactive Epitopes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.025

Epitope determinants of a chimpanzee Fab antibody that efficiently cross-neutralizes dengue type 1 and type 2 viruses map to inside and in close proximity to fusion loop of the dengue type 2 virus envelope glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.025

Epitope model of tick-borne encephalitis virus envelope glycoprotein E: analysis of structural properties, role of carbohydrate side chain, and conformational changes occurring at acidic pH.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.025

Differential expression of domain III neutralizing epitopes on the envelope proteins of West Nile virus strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.025

A ligand-binding pocket in the dengue virus envelope glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.025

Molecular basis of attenuation of neurovirulence of wild-type Japanese encephalitis virus strain SA14.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.025

The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.025

10.1016/J.VIROL.2006.05.025

7 January 2021

Identifiers

DOI

1 reference

20 September 2017

1 reference